zxclear

zxclear

[KR-바이오] 06/11 Korea Market Insights

삼성바이오로직스중립 The recent news flow for Samsung Biologics presents a dichotomy between robust operational fundamentals and lingering labor-management risks. From a financial perspective, the company continues to command strong market confidence, evidenced by a target price of 1.9 million KRW.…

[KR-모빌리티] 06/09 Korea Market Insights

현대차호재 Hyundai Motor’s recent strategic initiatives signal a robust transformation in both operational efficiency and future-tech leadership. The move to reduce manufacturing costs by 20% through (Manufacturing Innovation) is a critical catalyst for margin expansion, directly addressing investor concerns regarding…